Meth psychosis may worsen heart risks, new study suggests
NCT ID NCT07459244
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at heart electrical patterns (ECGs) in 240 people hospitalized for methamphetamine use, comparing those with and without psychosis. Researchers will check ECGs at admission and before discharge to see if psychosis is linked to more heart strain. The goal is to better understand cardiac risks in this population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors identify which methamphetamine users are at higher risk for heart problems, leading to better monitoring and care.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly change care. Results may not apply to all users, and ECG changes may not predict real-world heart events.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHAMPHETAMINE INDUCED PSYCHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Elazığ Mental Health and Diseases Hospital
RECRUITINGElâzığ, Elâzığ, 23200, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a psychedelic help break meth addiction in people with HIV?
- Weight-Loss drug may curb stimulant cravings, brain scans suggest
- Could an antidepressant help curb meth use in people treated for opioid addiction?
- Hormone therapy shows promise in preventing relapse in postpartum meth users
- Could ketamine therapy help people quit meth?
- Could a diabetes drug curb ice addiction? new trial aims to find out